Our website uses its own and third parties cookies for a high level of user-friendliness. If you continue to browse and  use this website we will assume that you agree with the policies.



System of pharmacogenomic evaluation for breast cancer treatment with aromatase inhibitors according to a new application designed by ROVI Laboratories

The project's overall objective optimization of management processes and drug delivery

Consortium with Laboratorios Rovi, Biomedadl, Vaxdyn, Hospital Virgen del Rocío, Universidad de Granada, Universidad de Sevilla, Universidad de Cádiz and Genyo.

Program FEDER-INNTERCONECTA for Andalucía